Document is current
Any future updates will be listed below
-
Authors
Shirakawa, Kenshu
Takeno, Masafumi
Kuma, Hidekazu
Terahara, Takaaki
Yamaguchi, Shigeki
-
Funding
Funding for this research was provided by:
Hisamitsu Pharmaceutical Co., Inc.
- License Information
-
More Information
Article History
Received: 9 October 2024
Accepted: 20 November 2024
First Online: 17 December 2024
Declarations
:
: Shigeki Yamaguchi has received honoraria from Hisamitsu Pharmaceutical Co., Inc., and The Nakatomi Foundation. Shigeki Yamaguchi is an Editorial Board member of Pain and Therapy. Shigeki Yamaguchi was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Kenshu Shirakawa has received honoraria from Hisamitsu Pharmaceutical Co., Inc. Takaaki Terahara, Hidekazu Kuma, and Masafumi Takeno are employees of Hisamitsu Pharmaceutical Co., Inc., Tokyo, Japan.
: This study was conducted in compliance with the Declaration of Helsinki of 1964. Protocol approval for the conduct of this study was obtained from the Medical Corporation Heishinkai OPHAC Hospital Institutional Review Board. All volunteers provided written informed consent for the use of their blood in the study. Throughout the study period, no ethical problems or medical malpractice occurred and the identities of the volunteers were kept confidential.
